Company news

Microba Life Sciences Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Update on Commercial Terms for Proposed Merger with MAP

October 20, 2026

Q1 FY27 Quarterly Activities Report & Appendix 4C

October 19, 2026

Q1 FY27 Quarterly Activities Report & Appendix 4C

October 19, 2026

Microba secures $2m placement and increases cost reductions

October 19, 2026

Microba secures $2m placement and increases cost reductions

October 19, 2026

Appointment of Interim Chief Executive Officer

September 24, 2026

GSS and MAP agree to Commercial Terms for Merger

September 21, 2026

2026 Annual Report & Appendix 4E

August 30, 2026

Genetic Signatures and Microba in Merger Discussions

August 25, 2026

Q4 FY26 Quarterly Investor Presentation & Webinar

July 15, 2026

Investor presentation - path to cashflow breakeven

June 11, 2026

Pause in Trading

June 2, 2026

Q3 FY26 Quarterly Investor Presentation & Webinar

April 29, 2026

Appendix 4D & FY26 Interim Report

February 25, 2026

Q2 FY26 Quarterly Investor Presentation & Webinar

January 28, 2026

Q2 FY26 Quarterly Activities Report & Appendix 4C

January 28, 2026

Microba receives $3 million R&D Tax Incentive Refund

December 2, 2025

Q1 FY26 Quarterly Investor Presentation & Webinar

October 27, 2025

Q1 FY26 Quarterly Activities Report & Appendix 4C

October 27, 2025

2025 Annual Report & Appendix 4E

August 26, 2025

Q4 FY25 Quarterly Investor Presentation & Webinar

July 21, 2025

Q4 FY25 Quarterly Activities Report & Appendix 4C

July 21, 2025

Disclosure Document - Prospectus

June 27, 2025

Strategic Investment & Equity Raise Presentation

June 23, 2025

Reinstatement to Quotation

June 23, 2025

Microba secures $14.5 million to drive clinical adoption

June 23, 2025

Suspension from Quotation

June 23, 2025

Trading Halt

June 18, 2025

MetaPanel Pathogen Study Delivers Breakthrough Results

May 20, 2025

Microba Announces Landmark GI Study Results From Over 4,600 Patients

May 14, 2025

Landmark GI Study Results from over 4,600 patients

May 13, 2025

Q3 FY25 Quarterly Investor Presentation & Webinar

April 29, 2025

Q3 FY25 Quarterly Activities Report & Appendix 4C

April 29, 2025

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

April 29, 2025

Appendix 4D & FY25 Interim Report

February 25, 2025

Q2 FY25 Quarterly Investor Presentation & Webinar

January 28, 2025

Q2 FY25 Quarterly Activities Report & Appendix 4C

January 28, 2025

Trading Update

November 28, 2024

Microba receives $6 million R&D Tax Incentive Refund

November 17, 2024

Q1 FY25 Quarterly Investor Presentation

October 28, 2024

Q1 FY25 Quarterly Activities Report & Appendix 4C

October 28, 2024

2024 Annual Report & Appendix 4E

August 28, 2024

Q4 FY24 Quarterly Investor Presentation & Webinar

July 24, 2024

Q4 FY24 Quarterly Activities Report & Appendix 4C

July 24, 2024

Completion of Autoimmune Program with Ginkgo Bioworks

June 27, 2024

Q3 FY24 Quarterly Investor Presentation

April 22, 2024

Q3 FY24 Quarterly Activities Report & Appendix 4C

April 22, 2024

Microba receives $6.08 million R&D Tax Incentive Refund

April 10, 2024

MetaPanel Launch Investor Presentation

March 12, 2024

MetaPanel Diagnostic Test Launched with Sonic Healthcare

March 12, 2024

Older news releases →

Calls

The 5 newest of 10 calls. Every call is listed under its year.

Decks

The 5 newest of 42 decks. Every deck is listed under its year.